October 13, 2026

GRAIL, Inc. (GRAL) Stock Analysis: Navigating the Diagnostic Revolution with a 25.7% Revenue Growth Potential

GRAIL, Inc. (NASDAQ: GRAL) stands out as a pioneering entity in the healthcare sector, particularly within the diagnostics and research industry. With its headquarters in Menlo..

Novavax, Inc. (NVAX) Investor Outlook: Evaluating the 11.48% Upside Potential Amidst a Challenging Landscape

As investors navigate the ever-evolving biotechnology sector, Novavax, Inc. (NASDAQ: NVAX) emerges as a compelling case study in both opportunity and caution. With a market capitalization..

Structure Therapeutics Inc. (GPCR) Stock Analysis: Unveiling a Potential 342% Upside for Savvy Investors

Structure Therapeutics Inc. (NASDAQ: GPCR) stands at an intriguing juncture for investors, especially in the high-stakes biotechnology sector. As a clinical-stage biopharmaceutical company, it is focused..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: 197% Potential Upside Beckons Investors

Ascentage Pharma Group International (AAPG), a dynamic player in the biotechnology sector, is drawing significant attention from investors due to its formidable growth potential and strategic..

CRISPR Therapeutics AG (CRSP) Stock Analysis: A Gene-Editing Pioneer with Nearly 70% Upside Potential

Investors with an appetite for innovation in biotechnology might find CRISPR Therapeutics AG (NASDAQ: CRSP) an intriguing prospect. As a pioneer in the field of gene..

Evolent Health, Inc (EVH) Stock Analysis: A Look at the 35% Upside Potential Amidst Robust Revenue Growth

Evolent Health, Inc (EVH) is capturing attention in the healthcare sector with a notable 35.29% potential upside, as evidenced by its average target price of $5.75..

Alvotech (ALVO) Stock Analysis: Exploring a 23.64% Potential Upside in the Biosimilars Market

Alvotech (NASDAQ: ALVO) is attracting attention in the investment community with a notable potential upside of 23.64%, as per analysts’ average target prices. As a player..

Astrana Health Inc. (ASTH) Stock Analysis: Strong Buy Ratings Signal 34.55% Potential Upside

Astrana Health Inc. (NASDAQ: ASTH) is a burgeoning player in the healthcare sector, particularly within the medical care facilities industry. With a market capitalization of $1.9..

Pacira BioSciences, Inc. (PCRX) Stock Analysis: Navigating the Complex Landscape of Non-Opioid Pain Management

Pacira BioSciences, Inc. (NASDAQ: PCRX) stands at the forefront of innovative solutions in the healthcare sector, specializing in non-opioid pain management and regenerative health solutions. With..

Schrodinger, Inc. (SDGR) Stock Analysis: Navigating Growth Amidst Potential Downsides

Schrodinger, Inc. (NASDAQ: SDGR) stands out in the healthcare sector, particularly within the health information services industry, by leveraging its innovative physics-based computational platform. This approach..

NeoGenomics, Inc. (NEO) Stock Analysis: Exploring a 33% Upside Potential

NeoGenomics, Inc. (NASDAQ: NEO), a prominent player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors with a potential upside..

Phreesia, Inc. (PHR) Stock Analysis: Healthcare SaaS Leader with 30% Upside Potential

Phreesia, Inc. (PHR) stands out in the healthcare sector with innovative SaaS-based solutions designed to streamline operations and enhance patient engagement for medical organizations across the..

Ligand Pharmaceuticals (LGND) Stock Analysis: Strong Buy Ratings Propel 10.65% Upside Potential

Ligand Pharmaceuticals Incorporated (NASDAQ: LGND), a prominent player in the biotechnology sector, offers a compelling opportunity for investors seeking growth in the healthcare industry. With a..

Amphastar Pharmaceuticals, Inc. (AMPH): Investor Outlook on a Specialty Drug Manufacturer with a Solid Growth Potential

Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH), a prominent player in the healthcare sector, specializes in the development, manufacture, and commercialization of generic and proprietary injectable, inhalation, and..

MannKind Corporation (MNKD) Stock Analysis: Potential Upside of 150% Amidst Strong Revenue Growth

MannKind Corporation (NASDAQ: MNKD), a biopharmaceutical company dedicated to transforming chronic disease care, is capturing the attention of investors with its notable market potential in the..

Establishment Labs Holdings Inc (ESTA) Stock Analysis: Healthcare Innovator with a 66% Potential Upside

Establishment Labs Holdings Inc (NASDAQ: ESTA) has emerged as a noteworthy player in the healthcare sector, specifically within the medical devices industry. This Austin, Texas-based company..

Pulse Biosciences, Inc. (PLSE) Stock Analysis: Exploring the 7.72% Potential Upside in the Innovative Healthcare Sector

Pulse Biosciences, Inc. (NASDAQ: PLSE) is making waves in the healthcare industry with its cutting-edge bioelectric medicine technologies. Based in Miami, Florida, this company has established..

Viridian Therapeutics, Inc. (VRDN) Stock Analysis: Exploring a Potential 100% Upside

Viridian Therapeutics, Inc. (NASDAQ: VRDN) has captured the attention of the investment community, primarily due to its promising pipeline targeting serious and rare diseases. With a..

Neogen Corporation (NEOG) Stock Analysis: A 16.67% Upside Potential Fuels Investor Optimism

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector’s medical devices industry, has garnered attention among investors due to its compelling growth prospects and..

Dyne Therapeutics, Inc. (DYN) Stock Analysis: Exploring the 123.89% Potential Upside

Dyne Therapeutics, Inc. (DYN) is capturing the attention of the investor community with a staggering potential upside of 123.89%. As a clinical-stage biotechnology company based in..

Search

Funds

October 13, 2026

Search

Funds

October 13, 2026

FTSE 100

Funds